The Use of Biologic Therapies in Uveitis. - Wikidata - awgldk - TriplyDB

The Use of Biologic Therapies in Uveitis.

The Use of Biologic Therapies in Uveitis.

http://www.wikidata.org/entity/Q38272248

about

Recent advances in managing and understanding uveitis.Roles of IL-6 in Ocular Inflammation: A Review.Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis.Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.Autoimmunity in 2014.

P2860

Q37709700-31632999-A4E5-40CA-9BD6-83F4C21B9DFC Q38986592-1A63A3E0-1B18-4CD1-993A-6A60EC37E0D2 Q39147540-FB98CB5C-3EDD-40BB-B60A-87A1E7CED264 Q40045785-963AF876-73DA-4F86-81B1-51E108E597DC Q42643483-1FEB47C0-C044-48FE-BB09-58F2D7225A7E

P2860

The Use of Biologic Therapies in Uveitis.

http://www.wikidata.org/entity/Q38272248

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The Use of Biologic Therapies in Uveitis.

@en

type

label

The Use of Biologic Therapies in Uveitis.

@en

prefLabel

The Use of Biologic Therapies in Uveitis.

@en

P1433

Q38272248-2434A2C1-60D1-44F5-BCB4-ADDAE4DB5544

P1476

Q38272248-025E748A-1596-4212-BC2F-74074F084C9B

P2093

Q38272248-4573AAFC-AA41-4044-AD4E-070F437C4878

Q38272248-7273F9D4-7829-4E16-9E83-8A380B6DC27A

P2860

Q38272248-01C37996-0052-47F0-9185-D5C20C19BC74

Q38272248-05CB2D91-21AB-46E4-8BCA-D133546CA399

Q38272248-06859D7E-A85E-4751-9708-F0491FB1AFCD

Q38272248-07600913-6C55-40B1-85CA-62E0A99DD16F

Q38272248-087934C9-C110-476B-9E27-B68FD1A768F5

Q38272248-08FBD9E8-F61B-4B0D-BF5E-ABB55C104F22

Q38272248-09E609F2-F05D-4604-8023-6AF8CED209CF

Q38272248-105A0471-EBA6-4314-890C-1E77A4AB2D8A

Q38272248-116C6F87-742D-4669-B771-957E84B59283

Q38272248-1610B4EC-854B-4625-99D9-3D05D6CD1018

P2888

Q38272248-5A397CB3-3932-4654-8D44-9E0F2FEA6A25

P304

Q38272248-5917CADE-2ACA-4456-B9FF-AFC11A7105D7

P31

Q38272248-0A518301-8B4F-4368-A6D6-1A35B1148DCB

P356

Q38272248-1920140E-CDC1-4100-A3DC-CAA6C73E18A9

P433

Q38272248-8964014F-5BA2-456C-B7A7-F5789AACA80E

P478

Q38272248-9EFCEDEE-CB34-4F91-860D-59847E2FCAA6

P577

Q38272248-F2DF6E39-C318-49C4-9787-F2EE25416C97

P6179

Q38272248-EC5419A4-CB50-421F-9DD8-1812F9425425

P698

Q38272248-9ECC63F2-128D-4981-85C1-E68EE1D5E343

P921

Q38272248-04215C4E-6843-46BA-94A0-4A14CAFB44E6

P356

S12016-014-8455-6

P1433

Clinical Reviews in Allergy & Immunology

P1476

The Use of Biologic Therapies in Uveitis.

@en

P2093

Monica Schwartzman

http://www.w3.org/2001/XMLSchema#string

Sergio Schwartzman

http://www.w3.org/2001/XMLSchema#string

P2860

GRADE guidelines: 3. Rating the quality of evidence

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.

Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis.

Optic neuritis associated with adalimumab in the treatment of uveitis.

Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease

Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.

Adalimumab in the therapy of uveitis in childhood

Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

P2888

s12016-014-8455-6

P304

307-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-014-8455-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018977357

http://www.w3.org/2001/XMLSchema#string

P698

25431348

http://www.w3.org/2001/XMLSchema#string

P921